Sponsor Dossier
A Menarini
Sponsor Dossier for A Menarini. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABSTRAL
- Brand: ADENURIC
- Brand: ALLERTINE
- Brand: BRETARIS
- Brand: BRIMICA
- Brand: CRESTOR
- Brand: LOBIVON
- Brand: MONOFER
- Device (sponsor): Non-sterile scar management dressing, reusable
About
A Menarini is an Australian Private Company with ABN 62116935758, registered in NSW and currently active.
Portfolio
A Menarini has 15 brands on the ARTG, of which 12 are indexable and 11 carry a Product Information document. 9 brands are PBS-listed, 9 have a PBAC outcome on record, and 6 have an AusPAR on record. Notable brands include ABSTRAL, ADENURIC, ALLERTINE, BRETARIS, BRIMICA, CRESTOR, LOBIVON, MONOFER, NEBILET, ORFADIN, ORSERDU, RANEXA.
Therapeutic focus
— Cardiology: 4 brands — Respiratory: 2 brands — Haematology: 1 brand — Pain Management: 1 brand — Reproductive Health: 1 brand — Complementary Medicine: 1 brand — Rare Disease: 1 brand — Immunology: 1 brand — Musculoskeletal: 1 brand — Oncology: 1 brand — Dermatology: 1 brand
PBS footprint
9 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-09-01, across 9 brands with a PBAC outcome on record. The latest AusPAR is 2018-04-16, across 6 brands with an AusPAR on record.